Journal of the American College of Radiology最新文献

英文中文

American Cancer Society National Lung Cancer Roundtable Introduction for JACR Lung Cancer Screening Issue 美国癌症协会全国肺癌圆桌会议介绍JACR肺癌筛查问题

IF 5.1 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Journal of the American College of Radiology

Pub Date : 2025-12-01 DOI: 10.1016/j.jacr.2025.10.012

Ella A. Kazerooni MD, MS , Douglas E. Wood MD , Robert A. Smith PhD

引用次数: 0

REACHing for Patient-Centered Screening: Leveraging Mammography Pathways to Advance Lung Cancer Prevention 达到以患者为中心的筛查：利用乳房x线摄影途径推进肺癌预防

IF 5.1 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Journal of the American College of Radiology

Pub Date : 2025-12-01 DOI: 10.1016/j.jacr.2025.08.024

Kasen Wong MS , Sean Johnson MD , Yannan Lin MD, MPH, PhD , Hannah S. Milch MD , Ashley E. Prosper MD

引用次数: 0

What a Peer-Led, Community-Engaged Lung Cancer Screening Pilot Study Taught Us About Reaching Black Veterans 一项由同行领导、社区参与的肺癌筛查试点研究教会了我们如何接触黑人退伍军人

IF 5.1 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Journal of the American College of Radiology

Pub Date : 2025-12-01 DOI: 10.1016/j.jacr.2025.08.027

Lauren E. Kearney MD , Jacquelyn N. Pendergast MS , Anushka Sista MS , Anna M. Barker MS , Steven Abrams BS , Fatima G. Wilder MD, MPH, MSc , Leslie Chatelain Jr. MPH , Johanne Eliacin PhD , Gemmae M. Fix PhD , Renda Soylemez Wiener MD, MPH

引用次数: 0

A Pilot Study: Leveraging Mammography and Digital Outreach to Identify and Engage Women at Risk for Lung Cancer in Lung Cancer Screening 一项试点研究：利用乳房x光检查和数字外展来识别和参与肺癌筛查中有肺癌风险的妇女

IF 5.1 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Journal of the American College of Radiology

Pub Date : 2025-12-01 DOI: 10.1016/j.jacr.2025.07.022

Tali Amir MD , Molly P. Hogan MD , Varadan Sevilimedu DrPH , Elizabeth Schofield DrPH , Jamie Ostroff PhD , Lisa Carter-Bawa PhD, MPH, APRN

引用次数: 0

Systemic Challenges to Lung Cancer Screening in the Safety-Net Setting: Care and Informatics Fragmentation 安全网环境下肺癌筛查的系统性挑战：护理和信息碎片化

IF 5.1 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Journal of the American College of Radiology

Pub Date : 2025-12-01 DOI: 10.1016/j.jacr.2025.09.019

Haley I. Tupper MD, MS, MPH , Florence X. Doo MD, MA , Yannan Lin MD, MPH, PhD , Patrick Chen MASc, MPH , Ashley E. Prosper MD , Gery W. Ryan PhD , Sha’Shonda L. Revels MD, MS

Background

Despite being the leading cause of cancer death, <20% of eligible, at-risk Americans undergo lung cancer screening. Lung cancer risk is concentrated in lower-income populations, but Medicaid-insured populations consistently have the lowest screening rates across cancers. To improve lung cancer screening rates and outcomes, we must understand the systemic challenges of orchestrating a complete episode of multidisciplinary care, from radiographic screening to treatment, in the resource-limited, safety-net environment.

Methods

We performed a qualitative case study of purposively sampled imaging-based cancer screening programs in safety-net organizations serving high-need populations in Los Angeles County, identified by geospatial techniques. Using a semistructured guide, organizational screening experts were prompted in hour-long telephone interviews between November 28, 2023, and February 12, 2024, to describe their organization’s imaging-based “screening pipeline,” including how they interfaced with external organizations to complete multidisciplinary screening to treatment. Audio was securely recorded, transcribed, and analyzed, using inductive thematic analysis.

Results

Four diverse organizations provided insight. Respondents highlighted two main resource-intensive systemic challenges: (1) fragmentation of care across multiple organizations and (2) siloed health information, particularly imaging. These interrelated challenges precluded simplification or automation of screening processes, prompting organizations to resort to manual, labor-intensive workarounds to partially overcome these systemic issues.

Conclusion

Care and informatics fragmentation particularly deplete safety-net resources and cause organized cancer screening programs to be unduly labor-intensive in this setting. These challenges were prevalent even in well-established screening programs, like breast, reinforcing that comprehensive, equity-based screening solutions transcend individual organizations.

尽管肺癌是癌症死亡的主要原因，但20%的符合条件的高危美国人接受了肺癌筛查。肺癌的风险集中在低收入人群中，但医疗保险人群的癌症筛查率一直最低。为了提高肺癌筛查率和结果，我们必须了解在资源有限的安全网环境下，从放射学筛查到治疗，编排一个完整的多学科护理过程所面临的系统性挑战。方法通过地理空间技术，我们对洛杉矶县服务于高需求人群的安全网组织中基于成像的癌症筛查项目进行了定性案例研究。使用半结构化指南，组织筛查专家在2023年11月28日至2024年2月12日期间进行了长达一小时的电话采访，以描述他们组织基于成像的“筛查管道”，包括他们如何与外部组织对接以完成多学科筛查到治疗。音频被安全地记录、转录和分析，使用归纳主题分析。结果：四个不同的组织提供了洞察力。受访者强调了两个主要的资源密集型系统挑战：(1)跨多个组织的护理分散；(2)孤立的卫生信息，特别是成像信息。这些相互关联的挑战阻碍了筛选过程的简化或自动化，促使组织诉诸于人工，劳动密集型的工作方法来部分克服这些系统问题。结论：在这种情况下，护理和信息的碎片化尤其会耗尽安全网资源，并导致有组织的癌症筛查项目过度耗费劳动力。这些挑战甚至在完善的筛查项目中也很普遍，比如乳房检查，这加强了全面的、基于公平的筛查解决方案超越了个体组织。

{"title":"Systemic Challenges to Lung Cancer Screening in the Safety-Net Setting: Care and Informatics Fragmentation","authors":"Haley I. Tupper MD, MS, MPH , Florence X. Doo MD, MA , Yannan Lin MD, MPH, PhD , Patrick Chen MASc, MPH , Ashley E. Prosper MD , Gery W. Ryan PhD , Sha’Shonda L. Revels MD, MS","doi":"10.1016/j.jacr.2025.09.019","DOIUrl":"10.1016/j.jacr.2025.09.019","url":null,"abstract":"<div><h3>Background</h3><div>Despite being the leading cause of cancer death, <20% of eligible, at-risk Americans undergo lung cancer screening. Lung cancer risk is concentrated in lower-income populations, but Medicaid-insured populations consistently have the lowest screening rates across cancers. To improve lung cancer screening rates and outcomes, we must understand the systemic challenges of orchestrating a complete episode of multidisciplinary care, from radiographic screening to treatment, in the resource-limited, safety-net environment.</div></div><div><h3>Methods</h3><div>We performed a qualitative case study of purposively sampled imaging-based cancer screening programs in safety-net organizations serving high-need populations in Los Angeles County, identified by geospatial techniques. Using a semistructured guide, organizational screening experts were prompted in hour-long telephone interviews between November 28, 2023, and February 12, 2024, to describe their organization’s imaging-based “screening pipeline,” including how they interfaced with external organizations to complete multidisciplinary screening to treatment. Audio was securely recorded, transcribed, and analyzed, using inductive thematic analysis.</div></div><div><h3>Results</h3><div>Four diverse organizations provided insight. Respondents highlighted two main resource-intensive systemic challenges: (1) fragmentation of care across multiple organizations and (2) siloed health information, particularly imaging. These interrelated challenges precluded simplification or automation of screening processes, prompting organizations to resort to manual, labor-intensive workarounds to partially overcome these systemic issues.</div></div><div><h3>Conclusion</h3><div>Care and informatics fragmentation particularly deplete safety-net resources and cause organized cancer screening programs to be unduly labor-intensive in this setting. These challenges were prevalent even in well-established screening programs, like breast, reinforcing that comprehensive, equity-based screening solutions transcend individual organizations.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 12","pages":"Pages 1598-1604"},"PeriodicalIF":5.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Monitoring the Harms of Lung Cancer Screening: Why the Nonmalignant Resection Rate Is Our Best Bet 监测肺癌筛查的危害：为什么非恶性切除率是我们最好的选择

IF 5.1 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Journal of the American College of Radiology

Pub Date : 2025-12-01 DOI: 10.1016/j.jacr.2025.08.017

Christopher R. Caruso MD, MPH , Anil Vachani MD, MSCE , Roger Y. Kim MD, MSCE

引用次数: 0

Common Determinants of Lung Cancer Screening Uptake in Three High-Risk and Underserved Communities 在三个高风险和服务不足的社区肺癌筛查的共同决定因素

IF 5.1 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Journal of the American College of Radiology

Pub Date : 2025-12-01 DOI: 10.1016/j.jacr.2025.08.018

Shailly Pandey MD , Nicolas Anderson BS , Madison Snidarich BA , Ursula Tsosie MS , Brandon Omernik MS, CTTS , Meagan C. Brown PhD, MPH , Kristina Crothers MD , Casey Walsh PhD, MSW , Jehan Z. Budak MD , Elle Brooks MPH , Abigail Echo-Hawk MA , Matthew Triplette MD, MPH

Objective

Though lung cancer screening (LCS) has significant mortality benefits and has been recommended by the US Preventive Services Task Force since 2013, uptake has been low, especially in most underserved populations. The objective of this study was to harmonize qualitative data from three parallel studies focused on communities with historically high rates of tobacco use and who face lung cancer disparities—people with human immunodeficiency virus; individuals that identify as lesbian, gay, bisexual, transgender, queer or questioning, and others; and urban-dwelling American Indian or Alaska Native individuals—to understand common barriers and facilitators to LCS to inform clinical programming.

Methods

This qualitative study re-analyzed deidentified focus group transcripts from three recently conducted qualitative studies performed in partnership with these communities. Participants were all eligible, or near eligible, for LCS by US Preventive Services Task Force 2021 criteria. Transcripts were analyzed using inductive thematic analysis, with final themes mapped to the Health Equity Implementation Framework.

Results

A total of 26 focus groups or interviews were analyzed, including a total of 109 participants (people with human immunodeficiency virus, n = 43; individuals that identify as lesbian, gay, bisexual, transgender, queer or questioning, and others, n = 21; American Indian or Alaska Native, n = 45). Fifteen themes emerged that represented common determinants of LCS behavior across the domains of the Health Equity Implementation Framework. Themes demonstrated broad interest in LCS and preventive health care but multilevel barriers to LCS engagement and completion. Participants endorsed facilitators such as community engagement, patient-provider information sharing, and patient navigation to enhance LCS uptake.

Discussion

Despite several barriers to screening that contribute to low uptake, there are facilitators that could be used through multilevel interventions to support LCS in underserved high-risk populations.

尽管肺癌筛查（LCS）具有显著的死亡率优势，并且自2013年以来一直被美国预防服务工作组推荐，但使用率很低，特别是在大多数服务不足的人群中。本研究的目的是协调三个平行研究的定性数据，这些研究的重点是历史上烟草使用率高的社区和面临肺癌差异的人群——人类免疫缺陷病毒感染者；认为自己是女同性恋、男同性恋、双性恋、跨性别者、酷儿或质疑者等；以及居住在城市的美国印第安人或阿拉斯加原住民——了解LCS的常见障碍和促进因素，以便为临床规划提供信息。方法本定性研究重新分析了最近与这些社区合作进行的三个定性研究中未确定的焦点小组记录。根据美国预防服务工作组2021年的标准，参与者都符合或接近符合LCS的条件。使用归纳专题分析对抄本进行分析，最后将主题映射到卫生公平实施框架。结果共分析了26个焦点小组或访谈，包括109名参与者（人类免疫缺陷病毒感染者43名；女同性恋、男同性恋、双性恋、变性者、同性恋或有疑问者等21名；美国印第安人或阿拉斯加原住民45名）。出现了15个主题，它们代表了卫生公平实施框架各领域中LCS行为的共同决定因素。主题显示了对LCS和预防性保健的广泛兴趣，但对LCS的参与和完成存在多层次障碍。与会者支持社区参与、患者-提供者信息共享和患者导航等促进因素，以增强LCS的吸收。尽管筛查的一些障碍导致低吸收，但有一些促进因素可以通过多层次干预来支持服务不足的高危人群的LCS。

{"title":"Common Determinants of Lung Cancer Screening Uptake in Three High-Risk and Underserved Communities","authors":"Shailly Pandey MD , Nicolas Anderson BS , Madison Snidarich BA , Ursula Tsosie MS , Brandon Omernik MS, CTTS , Meagan C. Brown PhD, MPH , Kristina Crothers MD , Casey Walsh PhD, MSW , Jehan Z. Budak MD , Elle Brooks MPH , Abigail Echo-Hawk MA , Matthew Triplette MD, MPH","doi":"10.1016/j.jacr.2025.08.018","DOIUrl":"10.1016/j.jacr.2025.08.018","url":null,"abstract":"<div><h3>Objective</h3><div>Though lung cancer screening (LCS) has significant mortality benefits and has been recommended by the US Preventive Services Task Force since 2013, uptake has been low, especially in most underserved populations. The objective of this study was to harmonize qualitative data from three parallel studies focused on communities with historically high rates of tobacco use and who face lung cancer disparities—people with human immunodeficiency virus; individuals that identify as lesbian, gay, bisexual, transgender, queer or questioning, and others; and urban-dwelling American Indian or Alaska Native individuals—to understand common barriers and facilitators to LCS to inform clinical programming.</div></div><div><h3>Methods</h3><div>This qualitative study re-analyzed deidentified focus group transcripts from three recently conducted qualitative studies performed in partnership with these communities. Participants were all eligible, or near eligible, for LCS by US Preventive Services Task Force 2021 criteria. Transcripts were analyzed using inductive thematic analysis, with final themes mapped to the Health Equity Implementation Framework.</div></div><div><h3>Results</h3><div>A total of 26 focus groups or interviews were analyzed, including a total of 109 participants (people with human immunodeficiency virus, n = 43; individuals that identify as lesbian, gay, bisexual, transgender, queer or questioning, and others, n = 21; American Indian or Alaska Native, n = 45). Fifteen themes emerged that represented common determinants of LCS behavior across the domains of the Health Equity Implementation Framework. Themes demonstrated broad interest in LCS and preventive health care but multilevel barriers to LCS engagement and completion. Participants endorsed facilitators such as community engagement, patient-provider information sharing, and patient navigation to enhance LCS uptake.</div></div><div><h3>Discussion</h3><div>Despite several barriers to screening that contribute to low uptake, there are facilitators that could be used through multilevel interventions to support LCS in underserved high-risk populations.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 12","pages":"Pages 1552-1566"},"PeriodicalIF":5.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Proactive, Prediction-Driven Outreach for Lung Cancer Screening: Development and Feasibility of a Population Management Toolkit 肺癌筛查的前瞻性预测驱动外展：人口管理工具包的开发和可行性

IF 5.1 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Journal of the American College of Radiology

Pub Date : 2025-12-01 DOI: 10.1016/j.jacr.2025.09.003

Lauren E. Kearney MD , Julianne E. Brady MA , Jacquelyn Pendergast MS , Anna M. Barker MS , Gemmae M. Fix PhD , Tanner J. Caverly MD, MPH , Nichole T. Tanner MD, MSCR , Hannah Tosi MS , Amelia Tarren MS , Nhan V. Do MD , Danne Elbers PhD , Renda Soylemez Wiener MD, MPH

Background

Lung cancer screening (LCS) uptake is low and high-benefit patients often are not reached. This study developed and pilot tested a prediction-driven population management approach to proactively identify and engage high-benefit patients in LCS.

Study design and methods

This four-phase feasibility study included (1) formative interviews with clinicians and patients; (2) LCS population management toolkit development including a site-level dashboard displaying unscreened, LCS-eligible patients arranged by predicted LCS benefit derived from a validated multivariable model; (3) toolkit pilot testing by LCS coordinators at five sites; and (4) postpilot interviews. To ensure the toolkit was patient-centered and met clinical needs, we interviewed 14 LCS program clinicians, 6 primary care providers, and 18 patients in formative interviews and 8 LCS program clinicians in postpilot interviews. Transcripts were analyzed using rapid content analysis. Following user-centered design principles and focusing on key intervention elements, findings were applied to population management toolkit development.

Results

Clinicians and patients endorsed LCS population management with proactive outreach. Clinicians valued LCS coordinators using their expertise to engage high-benefit patients while reducing strain on primary care. Patients appreciated additional touchpoints and recommended clear outreach using letters and telephone calls, emphasizing team-based care and nonstigmatizing language. These insights informed development and refinement of an adaptable toolkit. After pilot testing, LCS coordinators reported positive experiences and suggested toolkit refinements.

Interpretation

A prediction-driven approach to population management and proactive outreach is feasible and acceptable to clinicians and patients. Further studies should test the impact of this approach on LCS uptake and outcomes.

背景：肺癌筛查（LCS）的接受程度较低，患者往往无法获得高效益。本研究开发并试点测试了一种预测驱动的人口管理方法，以主动识别和吸引LCS的高效益患者。研究设计和方法这项可行性研究分为四个阶段，包括：(1)对临床医生和患者进行形成性访谈；(2) LCS人群管理工具包开发，包括一个站点级仪表板，显示未筛选的LCS合格患者，根据经过验证的多变量模型得出的预测LCS获益进行排列；(3) LCS协调员在五个站点进行工具包试点测试；(4)试点后访谈。为了确保工具包以患者为中心并满足临床需求，我们在形成性访谈中采访了14名LCS项目临床医生、6名初级保健提供者和18名患者，在试点后访谈中采访了8名LCS项目临床医生。使用快速内容分析分析转录本。遵循以用户为中心的设计原则并注重关键干预要素，将研究结果应用于人口管理工具包开发。结果临床医生和患者对LCS人群管理的积极外展表示赞同。临床医生重视LCS协调员利用他们的专业知识吸引高效益患者，同时减少初级保健的压力。患者欣赏额外的接触点，并建议使用信件和电话进行明确的外联，强调团队护理和非污名化的语言。这些见解为适应性工具包的开发和细化提供了信息。在试点测试后，LCS协调员报告了积极的经验，并提出了改进工具包的建议。对临床医生和患者来说，以预测为导向的人口管理和主动外展方法是可行和可接受的。进一步的研究应该测试这种方法对LCS的吸收和结果的影响。

{"title":"Proactive, Prediction-Driven Outreach for Lung Cancer Screening: Development and Feasibility of a Population Management Toolkit","authors":"Lauren E. Kearney MD , Julianne E. Brady MA , Jacquelyn Pendergast MS , Anna M. Barker MS , Gemmae M. Fix PhD , Tanner J. Caverly MD, MPH , Nichole T. Tanner MD, MSCR , Hannah Tosi MS , Amelia Tarren MS , Nhan V. Do MD , Danne Elbers PhD , Renda Soylemez Wiener MD, MPH","doi":"10.1016/j.jacr.2025.09.003","DOIUrl":"10.1016/j.jacr.2025.09.003","url":null,"abstract":"<div><h3>Background</h3><div>Lung cancer screening (LCS) uptake is low and high-benefit patients often are not reached. This study developed and pilot tested a prediction-driven population management approach to proactively identify and engage high-benefit patients in LCS.</div></div><div><h3>Study design and methods</h3><div>This four-phase feasibility study included (1) formative interviews with clinicians and patients; (2) LCS population management toolkit development including a site-level dashboard displaying unscreened, LCS-eligible patients arranged by predicted LCS benefit derived from a validated multivariable model; (3) toolkit pilot testing by LCS coordinators at five sites; and (4) postpilot interviews. To ensure the toolkit was patient-centered and met clinical needs, we interviewed 14 LCS program clinicians, 6 primary care providers, and 18 patients in formative interviews and 8 LCS program clinicians in postpilot interviews. Transcripts were analyzed using rapid content analysis. Following user-centered design principles and focusing on key intervention elements, findings were applied to population management toolkit development.</div></div><div><h3>Results</h3><div>Clinicians and patients endorsed LCS population management with proactive outreach. Clinicians valued LCS coordinators using their expertise to engage high-benefit patients while reducing strain on primary care. Patients appreciated additional touchpoints and recommended clear outreach using letters and telephone calls, emphasizing team-based care and nonstigmatizing language. These insights informed development and refinement of an adaptable toolkit. After pilot testing, LCS coordinators reported positive experiences and suggested toolkit refinements.</div></div><div><h3>Interpretation</h3><div>A prediction-driven approach to population management and proactive outreach is feasible and acceptable to clinicians and patients. Further studies should test the impact of this approach on LCS uptake and outcomes.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 12","pages":"Pages 1536-1546"},"PeriodicalIF":5.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Beyond Early Detection—Reframing Radiology’s Role in Lung Cancer Care 超越早期发现-重塑放射学在肺癌治疗中的作用

IF 5.1 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Journal of the American College of Radiology

Pub Date : 2025-12-01 DOI: 10.1016/j.jacr.2025.10.011

Lisa Carter-Bawa PhD, MPH, APRN , Ashley E. Prosper MD , Julie A. Barta MD

引用次数: 0

Challenges and Opportunities for Rural Multidisciplinary Lung Cancer Care 农村多学科肺癌治疗的挑战与机遇

IF 5.1 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Journal of the American College of Radiology

Pub Date : 2025-12-01 DOI: 10.1016/j.jacr.2025.08.020

Margaret R. Walker MD, MPH , Kyle A. Burton MD , Diego E. Collazo-Irizarry MD , Wade Swenson MD, MPH, MBA , Joshua C. Pritchett MD , Noelle K. LoConte MD , Anand K. Narayan MD, PhD

Rural patient populations experience increased morbidity and mortality from lung cancer, the leading cause of cancer death in the United States. Lung cancer screening with low-dose chest CT reduces lung cancer deaths, yet rural patient populations experience barriers to screening, diagnosis, and treatment. The authors review challenges and opportunities across the continuum of multidisciplinary lung cancer care in rural communities. Specific focus is placed on innovative and scalable care delivery models, particularly those relevant to radiologists and radiation oncologists. Emerging strategies to address lung cancer care disparities in access include mobile low-dose lung cancer screening units, quality improvement initiatives, enhanced community engagement, and multimodal telehealth outreach. Leveraging community assets and multidisciplinary care models will help ensure that rural patient populations diagnosed with lung cancer achieve the best possible outcomes.

肺癌是美国癌症死亡的主要原因，农村患者的发病率和死亡率都在增加。低剂量胸部CT肺癌筛查可降低肺癌死亡率，但农村患者群体在筛查、诊断和治疗方面存在障碍。作者回顾了农村社区多学科肺癌治疗的挑战和机遇。特别关注创新和可扩展的护理交付模式，特别是与放射科医生和放射肿瘤学家相关的模式。为解决在获得肺癌护理方面的差距而出现的新战略包括：移动低剂量肺癌筛查单位、质量改进举措、加强社区参与和多模式远程保健外展。利用社区资产和多学科护理模式将有助于确保确诊肺癌的农村患者群体获得最好的可能结果。

{"title":"Challenges and Opportunities for Rural Multidisciplinary Lung Cancer Care","authors":"Margaret R. Walker MD, MPH , Kyle A. Burton MD , Diego E. Collazo-Irizarry MD , Wade Swenson MD, MPH, MBA , Joshua C. Pritchett MD , Noelle K. LoConte MD , Anand K. Narayan MD, PhD","doi":"10.1016/j.jacr.2025.08.020","DOIUrl":"10.1016/j.jacr.2025.08.020","url":null,"abstract":"<div><div>Rural patient populations experience increased morbidity and mortality from lung cancer, the leading cause of cancer death in the United States. Lung cancer screening with low-dose chest CT reduces lung cancer deaths, yet rural patient populations experience barriers to screening, diagnosis, and treatment. The authors review challenges and opportunities across the continuum of multidisciplinary lung cancer care in rural communities. Specific focus is placed on innovative and scalable care delivery models, particularly those relevant to radiologists and radiation oncologists. Emerging strategies to address lung cancer care disparities in access include mobile low-dose lung cancer screening units, quality improvement initiatives, enhanced community engagement, and multimodal telehealth outreach. Leveraging community assets and multidisciplinary care models will help ensure that rural patient populations diagnosed with lung cancer achieve the best possible outcomes.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 12","pages":"Pages 1609-1617"},"PeriodicalIF":5.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Journal of the American College of Radiology

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀